↓ Skip to main content

Treatment of Acne Vulgaris During Pregnancy and Lactation

Overview of attention for article published in Drugs, May 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

blogs
1 blog
twitter
5 X users
wikipedia
15 Wikipedia pages

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
119 Mendeley
Title
Treatment of Acne Vulgaris During Pregnancy and Lactation
Published in
Drugs, May 2013
DOI 10.1007/s40265-013-0060-0
Pubmed ID
Authors

Y. L. Kong, H. L. Tey

Abstract

Acne vulgaris is a common problem encountered by pregnant and lactating women. Unfortunately, in clinical practice, treatment is often not optimized as a result of the lack of safety data and unified recommendations on the use of the various anti-acne therapies. In this narrative review, current data on their safety is summarized. We recommend the use of topical medications as first-line treatment for acne vulgaris in pregnant and lactating women. These include antibiotics (erythromycin, clindamycin, metronidazole and dapsone), benzoyl peroxide, azelaic acid and salicylic acid. Oral agents and/or light-based therapy may be considered as second-line treatment. The former consists of oral macrolides (erythromycin and azithromycin), cephalexin or zinc compounds. Blue-violet or red light phototherapy may be used as monotherapy or in addition to topical and/or oral therapies. Hormonal therapy, antibiotics consisting of tetracyclines, co-trimoxazole and fluoroquinolones, and both oral and topical retinoids should be avoided.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Indonesia 1 <1%
Australia 1 <1%
Unknown 117 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 22 18%
Student > Master 19 16%
Student > Doctoral Student 10 8%
Student > Ph. D. Student 8 7%
Student > Postgraduate 6 5%
Other 19 16%
Unknown 35 29%
Readers by discipline Count As %
Medicine and Dentistry 44 37%
Pharmacology, Toxicology and Pharmaceutical Science 11 9%
Nursing and Health Professions 6 5%
Agricultural and Biological Sciences 5 4%
Biochemistry, Genetics and Molecular Biology 5 4%
Other 13 11%
Unknown 35 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 August 2023.
All research outputs
#2,666,676
of 23,532,144 outputs
Outputs from Drugs
#316
of 3,316 outputs
Outputs of similar age
#22,877
of 195,095 outputs
Outputs of similar age from Drugs
#4
of 35 outputs
Altmetric has tracked 23,532,144 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,316 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,095 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.